ReviewJournal of enzyme inhibition and medicinal chemistry2022

Glucokinase as an emerging anti-diabetes target and recent progress in the development of its agonists.

Yixin Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.